Clinical Trial Update: A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) in High Risk Abdominal Neuroblastoma [Phase 2]

View source ↗

Summary

A Phase II study evaluating intensity-modulated radiation therapy (IMRT) in high-risk abdominal neuroblastoma was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Abdominal Neuroblastoma | Phase 2 | Status: TERMINATED | Results posted: 2016-02-04